The Gamma Knife Market is becoming an important segment of advanced radiation therapy as hospitals adopt technologies capable of delivering highly focused treatment without conventional open surgery. The market was valued at approximately USD 0.56 billion in 2024 and is expected to reach USD 0.59 billion in 2025 and USD 0.97 billion by 2035, expanding at a 5.2% CAGR between 2025 and 2035. Technological advancement and growing interest in non-invasive treatment are key factors behind this expansion.

The market serves several clinical indications, with brain metastasis representing the largest segment. Cancer is showing faster growth as healthcare providers increasingly focus on precision treatment for malignant tumors. Gamma Knife systems are also used for conditions such as arteriovenous malformations and trigeminal neuralgia, giving manufacturers opportunities across multiple neurological applications.

Head applications account for the largest share by anatomy, reflecting the widespread use of Gamma Knife systems for intracranial conditions. The technology's precision allows radiation to be focused on specific targets, while surrounding healthy tissue can be better protected than with broader treatment approaches. Expanding clinical applications are also supporting interest in other anatomical areas.

The competitive landscape is increasingly influenced by digital technologies and advanced treatment planning. Imaging integration, precision targeting, software improvements, and AI-based planning tools are helping shape the next generation of Gamma Knife systems. Growing demand for non-invasive care and investments in healthcare infrastructure are further supporting adoption across specialized hospitals and treatment centers.

Regionally, North America represents about 45% of the global market, Europe holds around 30%, and Asia-Pacific accounts for approximately 20%. The Asia-Pacific region is expanding rapidly as healthcare systems invest in advanced cancer and neurological treatment capabilities. Future opportunities are expected in emerging markets, AI-supported treatment planning, improved imaging integration, precision technologies, and partnerships that expand access to specialized radiosurgery services.